Adaptive Biotechnologies Corp
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||
| – | – | – | – | – | 85.8 | 49.0 | 43.9 | 37.3 | 66.9 | 71.0 | 82.4 | 48.4 | 42.9 | 32.7 | 25.6 | 12.8 | 7.1 | 6.1 | 5.9 | 6.9 | 5.2 | 4.5 | 4.1 | 2.7 | 3.2 | 4.3 | 4.9 | 6.0 | 8.6 | 9.6 | 9.1 | 7.4 | 11.1 | |
| – | – | – | – | – | – | 6.5 | 6.5 | 6.3 | 11.6 | 8.5 | 10.9 | 7.7 | 8.3 | 7.3 | 6.5 | 3.6 | 2.2 | 2.1 | 2.3 | 3.0 | 2.5 | 2.2 | 2.3 | 1.7 | 2.2 | 3.4 | 4.4 | 6.0 | 9.8 | 11.8 | 11.5 | 10.1 | 23.8 | |
| – | – | – | – | – | 85.1 | – | – | 35.0 | 63.0 | 65.6 | 81.2 | 47.0 | 41.6 | 31.9 | 24.8 | 12.2 | 6.7 | 4.9 | 5.4 | 6.4 | 4.7 | 4.1 | 3.8 | 2.3 | 2.9 | 4.2 | 4.7 | 5.8 | 8.4 | 9.4 | 8.9 | 7.2 | 11.6 | |
| – | – | – | – | – | 25.2 | 17.8 | 19.2 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | 4.0% | 5.6% | 5.2% | -3.3% | -2.1% | -2.3% | -2.1% | -3.7% | -4.1% | -5.0% | -6.4% | -12.5% | -21.2% | -22.4% | -18.4% | -15.4% | -17.3% | -21.1% | -24.0% | -31.0% | -25.5% | -14.9% | -11.2% | -7.8% | -4.7% | -2.6% | -1.9% | -1.4% | -0.7% | |
| Margins | ||||||||||||||||||||||||||||||||||
| – | – | – | 64.7% | 64.7% | 69.1% | 72.3% | 73.8% | 75.7% | 76.3% | 75.9% | 77.1% | 76.6% | 75.2% | 71.9% | 68.1% | 66.0% | 65.6% | 66.9% | 68.7% | 65.6% | 64.1% | 59.6% | 55.6% | 57.1% | 54.8% | 58.5% | 59.7% | 62.5% | 66.0% | 71.8% | 74.2% | 75.3% | 75.4% | |
| – | – | – | -89.4% | -96.7% | -85.9% | -87.6% | -92.1% | -99.6% | -123.4% | -143.7% | -155.3% | -137.6% | -129.2% | -130.7% | -135.4% | -149.3% | -146.2% | -132.5% | -108.0% | -105.4% | -100.0% | -108.6% | -133.3% | -125.3% | -129.2% | -112.7% | -90.8% | -75.7% | -59.0% | -30.9% | -20.6% | -15.8% | -12.2% | |
| – | – | – | -83.4% | -89.5% | -80.4% | -78.5% | -80.6% | -87.5% | -108.0% | -132.3% | -148.6% | -134.1% | -128.3% | -129.9% | -134.2% | -148.4% | -145.3% | -131.8% | -108.1% | -105.9% | -100.7% | -109.0% | -132.3% | -123.2% | -126.5% | -110.1% | -89.1% | -74.8% | -59.1% | -31.5% | -21.5% | -16.8% | -20.7% | |
| – | – | – | -69.3% | 413.9% | 339.9% | 276.1% | 228.3% | -123.1% | -141.8% | -160.7% | -171.3% | -179.4% | -175.3% | -164.1% | -164.9% | -160.4% | -150.9% | -137.4% | -108.1% | -105.7% | -89.5% | -95.4% | -98.1% | -83.0% | -80.9% | -64.6% | -55.3% | -46.8% | -40.4% | -24.9% | -17.7% | -10.0% | -7.8% | |
| Returns | ||||||||||||||||||||||||||||||||||
| – | – | – | – | -18.2% | – | -10.5% | -12.0% | -14.8% | -18.8% | -15.8% | -19.7% | -21.4% | -24.7% | -29.2% | -34.3% | -41.5% | -44.8% | -45.4% | -43.1% | -46.0% | -48.2% | -54.2% | -73.0% | -78.2% | -88.4% | -87.2% | -78.7% | -74.5% | -67.5% | -38.9% | -27.2% | -23.0% | -44.7% | |
| – | – | – | -14.0% | -8.5% | -9.2% | -6.7% | -7.5% | -9.3% | -11.6% | -11.2% | -13.1% | -14.5% | -16.6% | -19.2% | -22.4% | -26.7% | -28.8% | -25.0% | -23.4% | -24.7% | -25.0% | -27.3% | -34.1% | -34.7% | -36.5% | -35.0% | -29.6% | -27.8% | -24.4% | -16.2% | -11.6% | -9.8% | -10.0% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||
| 192 | – | – | – | -111 | -46 | – | – | -211 | -362 | -493 | -120 | -169 | -179 | -117 | -134 | -106 | -68 | -209 | -81 | -85 | -100 | -79 | -56 | -62 | -50 | -28 | -38 | -40 | -33 | -46 | -57 | -63 | 174 | |
| – | – | – | -77.6% | 46.9% | -47.3% | 63.9% | 62.6% | 63.0% | 62.0% | 70.7% | 66.6% | 67.7% | 67.1% | 65.6% | 65.4% | 64.5% | 64.3% | 55.2% | 54.2% | 53.6% | 51.8% | 50.4% | 46.6% | 44.3% | 41.3% | 40.1% | 37.6% | 37.3% | 36.2% | 41.7% | 42.7% | 42.8% | 22.3% | |
| 0.0 | – | – | – | 0.0 | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 | 0.1 | 2.4 | |
| Per Share | ||||||||||||||||||||||||||||||||||
| – | – | – | -0.44 | -0.43 | -0.45 | -0.49 | -0.55 | -0.65 | -0.78 | -0.91 | -1.07 | -1.12 | -1.22 | -1.35 | -1.47 | -1.62 | -1.63 | -1.55 | -1.40 | -1.36 | -1.32 | -1.35 | -1.55 | -1.48 | -1.45 | -1.32 | -1.08 | -0.95 | -0.80 | -0.49 | -0.39 | -0.32 | -0.40 | |
| – | – | – | 0.53 | 0.48 | 0.56 | 0.63 | 0.68 | 0.74 | 0.72 | 0.69 | 0.72 | 0.83 | 0.95 | 1.04 | 1.09 | 1.09 | 1.12 | 1.18 | 1.30 | 1.28 | 1.31 | 1.24 | 1.18 | 1.20 | 1.14 | 1.20 | 1.22 | 1.27 | 1.35 | 1.55 | 1.81 | 1.90 | 1.95 | |
| 3.18 | – | – | -2.44 | 2.38 | -2.32 | 4.71 | 4.59 | 4.38 | 4.16 | 5.77 | 5.43 | 5.22 | 4.94 | 4.63 | 4.28 | 3.90 | 3.64 | 3.41 | 3.24 | 2.95 | 2.74 | 2.50 | 2.13 | 1.89 | 1.64 | 1.52 | 1.38 | 1.28 | 1.18 | 1.25 | 1.43 | 1.39 | 0.91 | |
| – | – | – | -0.36 | 2.01 | 1.92 | 1.73 | 1.56 | -0.91 | -1.03 | -1.10 | -1.23 | -1.50 | -1.67 | -1.71 | -1.80 | -1.75 | -1.69 | -1.61 | -1.40 | -1.36 | -1.18 | -1.18 | -1.15 | -0.99 | -0.93 | -0.78 | -0.67 | -0.59 | -0.54 | -0.39 | -0.32 | -0.19 | -0.15 | |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.